Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.250
-0.050 (-3.85%)
At close: Mar 28, 2025, 4:00 PM
1.260
+0.010 (0.76%)
Pre-market: Mar 31, 2025, 9:08 AM EDT

Editas Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1041058275971,7964,335
Upgrade
Market Cap Growth
-87.33%-87.33%38.68%-66.78%-58.56%188.64%
Upgrade
Enterprise Value
-131-1224161391,1683,820
Upgrade
Last Close Price
1.251.2710.138.8726.5570.11
Upgrade
PS Ratio
3.193.2410.5930.2770.3147.77
Upgrade
PB Ratio
0.770.782.371.653.2411.01
Upgrade
P/TBV Ratio
0.780.782.371.653.2411.01
Upgrade
EV/Sales Ratio
-5.327.0745.7142.10
Upgrade
Debt / Equity Ratio
0.260.260.110.120.050.07
Upgrade
Asset Turnover
0.080.080.150.030.040.17
Upgrade
Quick Ratio
3.713.715.275.8110.677.01
Upgrade
Current Ratio
3.753.755.395.9410.827.20
Upgrade
Return on Equity (ROE)
-98.10%-98.10%-43.17%-48.22%-40.64%-35.36%
Upgrade
Return on Assets (ROA)
-35.52%-35.52%-20.87%-23.70%-19.31%-15.58%
Upgrade
Return on Capital (ROIC)
-53.82%-53.82%-26.76%-28.68%-24.15%-23.70%
Upgrade
Earnings Yield
-228.59%-226.16%-18.52%-36.95%-10.72%-2.68%
Upgrade
FCF Yield
-211.25%-209.00%-16.55%-30.42%-9.56%-4.31%
Upgrade
Buyback Yield / Dilution
-8.39%-8.39%-10.63%-1.55%-15.37%-17.26%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q